Table 2.
870 | 871* | 873* | 874 | 875 | 877 | 878 | 879 | 880* | 881* | 882 | 883 | 884 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxycodone | 253.5 | 576.7 | 230.9 | 433.4 | 488.8 | 500.0 | 476.2 | 239.5 | 362.7 | 331.4 | 256.4 | 288.9 | 103.7 |
Hydrocodone | 293.5 | 414.6 | 213.1 | 588.2 | 479.4 | 634.6 | 381.0 | 179.6 | 470.6 | 286.0 | 382.5 | 279.2 | 332.0 |
Morphine | 40.0 | 56.6 | 17.8 | 31.0 | 61.7 | 38.5 | 0.0 | 59.9 | 45.8 | 18.2 | 21.0 | 38.5 | 41.5 |
OxyContin® | 126.8 | 232.5 | 124.3 | 201.2 | 182.7 | 211.5 | 381.0 | 59.9 | 147.1 | 99.9 | 79.9 | 77.0 | 83.0 |
Vicodin® and generic equivalents | 140.1 | 253.9 | 106.6 | 170.3 | 123.4 | 192.3 | 190.5 | 119.8 | 388.9 | 122.6 | 227.0 | 144.4 | 145.2 |
MS Contin® and generic equivalents | 26.7 | 36.7 | 0.0 | 15.5 | 40.3 | 19.2 | 0.0 | 59.9 | 26.1 | 9.1 | 4.2 | 14.4 | 20.7 |
Total No. Patients | 1499 | 6537 | 563 | 646 | 4214 | 520 | 105 | 167 | 3060 | 2203 | 2379 | 2077 | 482 |
= 3-digit ZIP codes where product-specific clusters of abuse observed after availability adjustment